ALZHEIMERS DISEASE RESEARCH FOUNDATION: Form 990, tax year 2021
View the entire original 990 at ProPublica ↗
- Organization
- ALZHEIMERS DISEASE RESEARCH FOUNDATION (EIN 52-2396428)
- Tax period
- 2021-01-01 to 2021-12-31
- Filed
- 2022-05-10
- IRS object ID
- 202241309349304019
- Schema version
- 2021v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule L
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2022-05-10T14:35:30-05:00 | ReturnTs |
| Tax Period End | 2021-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 050409384 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KAHN LITWIN RENZA & CO LTD | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 951 NORTH MAIN STREET | AddressLine1Txt |
| City | PROVIDENCE | CityNm |
| State Abbreviation | RI | StateAbbreviationCd |
| ZIP | 02904 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2021-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 522396428 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ALZHEIMER'S DISEASE RESEARCH FOUNDATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | ALZH | BusinessNameControlTxt |
| Phone | 7812373800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON ST 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | TIMOTHY W ARMOUR | PersonNm |
| Person Title | PRESIDENT | PersonTitleTxt |
| Phone | 7812373800 | PhoneNum |
| Signature | 2022-05-10 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | TIMOTHY | PersonFirstNm |
| Person Last | ARMOUR | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | SANDY ROSS | PreparerPersonNm |
| PTIN | P01399337 | PTIN |
| Phone | 4012742001 | PhoneNum |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 3 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2021 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CURE ALZHEIMER'S FUND | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | TIMOTHY W ARMOUR | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON ST 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $28,717,249 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | HTTP://CUREALZ.ORG/ | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2004 | FormationYr |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Activity Or Mission | TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 7 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 6 | VotingMembersIndependentCnt |
| Total Employee | 26 | TotalEmployeeCnt |
| Total Volunteers | 35 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $22,874,388 | PYContributionsGrantsAmt |
| CY Contributions Grants | $26,547,838 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $24,835 | PYInvestmentIncomeAmt |
| CY Investment Income | $32,050 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | -$7,161 | CYOtherRevenueAmt |
| PY Total Revenue | $22,899,223 | PYTotalRevenueAmt |
| CY Total Revenue | $26,572,727 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $14,050,077 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $17,719,354 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $2,410,583 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $3,128,684 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,473,932 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $4,545,719 | PYOtherExpensesAmt |
| CY Other Expenses | $2,317,237 | CYOtherExpensesAmt |
| PY Total Expenses | $21,006,379 | PYTotalExpensesAmt |
| CY Total Expenses | $23,165,275 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $1,892,844 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $3,407,452 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $16,427,042 | TotalAssetsBOYAmt |
| Total Assets EOY | $23,967,152 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $1,631,589 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $5,766,651 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $14,795,453 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $18,200,501 | NetAssetsOrFundBalancesEOYAmt |
| Mission | TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTHROPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $17,719,354 | ExpenseAmt |
| Grant | $17,719,354 | GrantAmt |
| Desc | IN 2021, CURE ALZHEIMER'S FUND SUPPORTED 77 RESEARCH PROJECTS AT 39 LEADING RESEARCH INSTITUTIONS, FOR RESEARCH OUTPUT OF MORE THAN $17 MILLION. MANY PROJECTS PURSUED A DEEPER UNDERSTANDING OF THE MECHANISMS OF ACTION OF THE GENES AND VARIANTS WITH THE BIGGEST IMPACT ON RISK AND TIMING OF ALZHEIMER'S DISEASE. OTHER PROJECTS PURSUED NOVEL THEORIES AND TOOLS TO ASSESS POTENTIAL AVENUES FOR PREVENTION AND TREATMENT, IN PARTICULAR REGARDING THE ROLE OF THE BRAIN'S INNATE IMMUNE SYSTEM AND THE CONTROL OF THE ENTRY AND EXIT OF MATERIALS FOR HEALTHY BRAIN FUNCTION. ADDITIONAL EXPENSES INCLUDE HUSBANDRY OF TRANSGENIC ANIMAL MODELS BY A CONTRACT RESEARCH ORGANIZATION; THE DIRECT SUPPORT OF FACILITATING GRANTS AND THE AWARD PROCESS; AND COSTS ASSOCIATED WITH ASSESSING RESEARCH PROPOSALS AND DETERMINING FUNDING PRIORITIES. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $2,962,292 | ExpenseAmt |
| Desc | CREATING AWARENESS TOOK THE FORM OF MAILINGS, OUTREACH, AND SUPPORT OF THIRD PARTY EVENTS DESIGNED TO RAISE AWARENESS ABOUT THE NEED OF MORE RESEARCH INTO THE ORIGINS AND PROGRESSION OF ALZHEIMER'S DISEASE. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $20,681,646 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | Yes (1) | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 21 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 26 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (1) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (1) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 7 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 6 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Other Website | Yes (X) | OtherWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TIMOTHY W ARMOUR | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 7812383800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON STREET STE 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (15 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| TIMOTHY ARMOUR | ||||||||
| PRESIDENT & CEO | 40.00 | Yes (X) | Yes (X) | $277,005 | $0 | $9,315 | ||
| BARBARA CHAMBERS | ||||||||
| EVP MARKETING & COMM. | 40.00 | $204,402 | $0 | $17,701 | Yes (X) | |||
| KATHARINE HERMAN | ||||||||
| EVP DEVELOPMENT | 40.00 | $408,231 | $0 | $28,438 | Yes (X) | |||
| JOHN SLATTERY | ||||||||
| SVP MAJOR GIFTS | 40.00 | $185,684 | $0 | $6,433 | Yes (X) | |||
| MARGARET SMITH | ||||||||
| EVP, RESEARCH ADMIN | 30.00 | $206,085 | $0 | $21,067 | Yes (X) | |||
| MAHUA DASGUPTA | ||||||||
| SR. PHILANTROPIC ADVISOR | 40.00 | $165,782 | $0 | $20,687 | Yes (X) | |||
| KELLY WESTERHOUSE | ||||||||
| VP GIVING | 40.00 | $139,693 | $0 | $9,029 | Yes (X) | |||
| LISA RAND | ||||||||
| VP MARKETING & COMM. | 40.00 | $133,345 | $0 | $10,672 | Yes (X) | |||
| LAUREL LYLE | ||||||||
| SECRETARY & VP BOARD RELATIONS AND DEVELOPMENT | 40.00 | Yes (X) | Yes (X) | $104,895 | $0 | $3,682 | ||
| JEFFREY MORBY | ||||||||
| CO-CHAIRMAN | 20.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| HENRY MCCANCE | ||||||||
| CO-CHAIRMAN | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| PHYLLIS RAPPAPORT | ||||||||
| TREASURER | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| ROBERT GREENHILL | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JACQUELINE MORBY | ||||||||
| DIRECTOR | 5.00 | Yes (X) | $0 | $0 | $0 | |||
| SHERRY SHARP | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $1,825,122 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $127,024 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 9 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (4 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| GRYPHON CONSULTING INC | |||||
| 21 DEAN ST | BELMONT | MA | 02478 | FINANCIAL & MGT CONSULTANT | $190,775 |
| PEARL STREET COLLECTIVE LLC | |||||
| 145 CHADWICK STREET | NORTH ANDOVER | MA | 01845 | RECRUITING EXPENSES | $131,847 |
| PROPER VILLIANS INC | |||||
| 2 SEAPORT LANE 7TH FLOOR | BOSTON | MA | 02210 | CREATIVE AND PRODUCTION SERVICES | $121,411 |
| JOANNE RENCHER & ASSOCIATES LLC | |||||
| 1 BRIARWOOD COURT | WARWICK | NY | 10990 | HR SERVICES | $102,500 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 4 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $253,982 | FundraisingAmt |
| All Other Contributions | $26,293,856 | AllOtherContributionsAmt |
| Noncash Contributions | $5,208,766 | NoncashContributionsAmt |
| Total Contributions | $26,547,838 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $4,497 | TotalRevenueColumnAmt |
| Exclusion | $4,497 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $2,093,774 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $2,066,221 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $27,553 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $27,553 | TotalRevenueColumnAmt |
| Exclusion | $27,553 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $71,140 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $253,982 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $78,301 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$7,161 | TotalRevenueColumnAmt |
| Exclusion | -$7,161 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $26,572,727 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $24,889 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $16,141,813 | TotalAmt |
| Program Services | $16,141,813 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,577,541 | TotalAmt |
| Program Services | $1,577,541 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,472,939 | TotalAmt |
| Program Services | $994,241 | ProgramServicesAmt |
| Management And General | $285,627 | ManagementAndGeneralAmt |
| Fundraising | $193,071 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,289,329 | TotalAmt |
| Program Services | $555,739 | ProgramServicesAmt |
| Management And General | $98,372 | ManagementAndGeneralAmt |
| Fundraising | $635,218 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $43,271 | TotalAmt |
| Program Services | $18,728 | ProgramServicesAmt |
| Management And General | $3,565 | ManagementAndGeneralAmt |
| Fundraising | $20,978 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $105,847 | TotalAmt |
| Program Services | $48,171 | ProgramServicesAmt |
| Management And General | $13,937 | ManagementAndGeneralAmt |
| Fundraising | $43,739 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $217,298 | TotalAmt |
| Program Services | $135,775 | ProgramServicesAmt |
| Management And General | $25,097 | ManagementAndGeneralAmt |
| Fundraising | $56,426 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $35,656 | TotalAmt |
| Program Services | $27,644 | ProgramServicesAmt |
| Management And General | $7,560 | ManagementAndGeneralAmt |
| Fundraising | $452 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $192,212 | TotalAmt |
| Management And General | $192,212 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $72,000 | TotalAmt |
| Program Services | $72,000 | ProgramServicesAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $40 | TotalAmt |
| Management And General | $40 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $527,249 | TotalAmt |
| Program Services | $183,341 | ProgramServicesAmt |
| Management And General | $201,492 | ManagementAndGeneralAmt |
| Fundraising | $142,416 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $782,714 | TotalAmt |
| Program Services | $732,534 | ProgramServicesAmt |
| Fundraising | $50,180 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $183,549 | TotalAmt |
| Program Services | $43,150 | ProgramServicesAmt |
| Management And General | $51,027 | ManagementAndGeneralAmt |
| Fundraising | $89,372 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $80,543 | TotalAmt |
| Program Services | $8,689 | ProgramServicesAmt |
| Management And General | $71,854 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $182,873 | TotalAmt |
| Program Services | $102,240 | ProgramServicesAmt |
| Management And General | $24,888 | ManagementAndGeneralAmt |
| Fundraising | $55,745 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,292 | TotalAmt |
| Program Services | $1,286 | ProgramServicesAmt |
| Management And General | $2,027 | ManagementAndGeneralAmt |
| Fundraising | $3,979 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $38,976 | TotalAmt |
| Program Services | $15,590 | ProgramServicesAmt |
| Fundraising | $23,386 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,433 | TotalAmt |
| Management And General | $8,433 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,299 | TotalAmt |
| Program Services | $4,136 | ProgramServicesAmt |
| Management And General | $11,163 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (2 entries)
| DescDesc | TotalTotalAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt | Program ServicesProgramServicesAmt |
|---|---|---|---|---|
| GIFT PROCESSING FEES | $143,594 | $97 | $143,497 | |
| MISCELLANEOUS | $46,807 | $12,306 | $15,473 | $19,028 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $23,165,275 | TotalAmt |
| Program Services | $20,681,646 | ProgramServicesAmt |
| Management And General | $1,009,697 | ManagementAndGeneralAmt |
| Fundraising | $1,473,932 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,191,794 | BOYAmt |
| EOY | $4,850,918 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $207,998 | BOYAmt |
| EOY | $4,457,855 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,593,695 | BOYAmt |
| EOY | $1,496,905 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $55,727 | BOYAmt |
| EOY | $160,657 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $54,458 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $47,509 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,382 | BOYAmt |
| EOY | $6,949 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,362,446 | BOYAmt |
| EOY | $12,993,868 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $16,427,042 | BOYAmt |
| EOY | $23,967,152 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $959,088 | BOYAmt |
| EOY | $430,625 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $5,103,487 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $500,000 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $172,501 | BOYAmt |
| EOY | $232,539 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,631,589 | BOYAmt |
| EOY | $5,766,651 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,674,191 | BOYAmt |
| EOY | $16,316,372 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,121,262 | BOYAmt |
| EOY | $1,884,129 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,795,453 | BOYAmt |
| EOY | $18,200,501 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $16,427,042 | BOYAmt |
| EOY | $23,967,152 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $3,407,452 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$2,404 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $17,501,551 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $19,798,072 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $30,497,342 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $22,873,948 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $26,576,211 | CurrentTaxYearAmt |
| Total | $117,247,124 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $17,501,551 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $19,798,072 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $30,497,342 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $22,873,948 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $26,576,211 | CurrentTaxYearAmt |
| Total | $117,247,124 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $15,353,332 | SubstantialContributorsTotAmt |
| Public Support Total170 | $101,893,792 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $13,021 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $77,320 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $83,306 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $15,472 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $4,497 | CurrentTaxYearAmt |
| Total | $193,616 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,644 | CurrentTaxYearMinus4YearsAmt |
| Total | $3,644 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $117,444,384 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $24,340 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.86760 | PublicSupportCY170Pct |
| Public Support PY170 | 0.87800 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | 0 | VolunteersInd |
| Paid Staff Or Management | 0 | PaidStaffOrManagementInd |
| Media Advertisements | 0 | MediaAdvertisementsInd |
| Mailings Members | 0 | MailingsMembersInd |
| Publications Or Broadcast | 0 | PublicationsOrBroadcastInd |
| Grants Other Organizations | 0 | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (1) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $72,000 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | 0 | RalliesDemonstrationsInd |
| Other Activities | 0 | OtherActivitiesInd |
| Total Lobbying Expenditures | $72,000 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | 0 | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II-B, LINE 1(G) | FormAndLineReferenceDesc |
| Explanation | A REGISTERED LOBBYIST CONTACTED VARIOUS CONGRESSIONAL LEGISLATORS FOR THE PURPOSE OF ENCOURAGING INCREASED FUNDING OF ALZHEIMER'S DISEASE RESEARCH BY THE FEDERAL GOVERNMENT. | ExplanationTxt |
Schedule D IRS990ScheduleD
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $54,458 | OtherCostOrOtherBasisAmt |
| Depreciation | $47,509 | DepreciationAmt |
| Book Value | $6,949 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $6,949 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | ACCRUED PAYROLL AND RELATED | Desc |
| Amt | $232,539 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $232,539 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $26,570,283 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$2,404 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | -$2,404 | RevenueNotReportedAmt |
| Revenue Subtotal | $26,572,687 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $40 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $40 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $26,572,727 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $23,165,235 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $23,165,235 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $40 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $40 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $23,165,275 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION IS EXEMPT FROM INCOME TAXES AS A PUBLIC CHARITY UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. MANAGEMENT BELIEVES THAT THE ORGANIZATION OPERATES IN A MANNER CONSISTENT WITH ITS TAX-EXEMPT STATUS AT BOTH THE STATE AND FEDERAL LEVEL. THE ORGANIZATION ANNUALY FILES IRS FORM 990- RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX REPORTING VARIOUS INFORMATION THAT THE IRS USES TO MONITOR THE ACTIVITIES OF TAX-EXEMPT ENTITIES. THESE TAX RETURNS ARE SUBJECT TO REVIEW BY THE TAXING AUTHORITIES, GENERALLY FOR A PERIOD OF THREE YEARS AFTER THEY WERE FILED. THE ORGANIZATION CURRENTLY HAS NO TAX EXAMINATIONS IN PROGESS. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | GRANTS AWARDED | ALZHEIMER'S DISEASE RESEARCH | $1,098,566 |
| NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 0 | 0 | GRANTS AWARDED | ALZHEIMER'S DISEASE RESEARCH | $249,550 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | GRANTS AWARDED | ALZHEIMER'S DISEASE RESEARCH | $229,425 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $1,577,541 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $1,577,541 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (10 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt |
|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | SIGNALING FUNCTION OF TREM2 CLEAVAGE PRODUCTS, WHICH ARE AFFECTED BY AGONISTIC ANTIBODIES TO THE STALK REGION | $172,500 | ACH | $0 |
| NORTH AMERICA | APOE CONSORTIUM: TOWARD DEVELOPING HIGH DENSITY LIPOPROTEIN ENRICHED IN APOLIPOPROTEIN E AS A POTENTIAL BIOMARKER AND THERAPEUTIC TARGETING VASCULAR CONTRIBUTIONS TO ALZHEIMER'S DISEASE | $249,550 | ACH | $0 |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | TARGETING TAUOPATHIES WITH ANTISENSE OLIGONUCLEOTIDES TO SYNAPTOGYRIN-3 | $129,375 | ACH | $0 |
| MIDDLE EAST AND NORTH AFRICA | "UNDERSTANDING THE MECHANISM UNDERLYING VACCINATION FOR ALZHEIMER'S DISEASE" | $229,425 | ACH | $0 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | EXTRACELLULAR ATP IS A KEY FACTOR IN PROMOTING ALZHEIMER'S DISEASE NEUROINFLAMMATION | $67,500 | ACH | $0 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | EXTRACELLULAR ATP IS A KEY FACTOR IN PROMOTING ALZHEIMER'S DISEASE NEUROINFLAMMATION | $105,000 | ACH | $0 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | INFLUENCE OF PLAQUE VICINITY ON MICROGLIAL AND ASTROCYTE GENE EXPRESSION; ROLE OF HUMAN TAU AND TREM2 | $172,289 | ACH | $0 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | NEUROINFLAMMATION CONTRIBUTIONS TO ALZHEIMER'S DISEASE: ROLE OF THE CHOROID PLEXUS | $34,500 | ACH | $0 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | CIRCUITS: CHARACTERIZING EPIGENETIC BIOMARKERS OF HUMAN COGNITIVE AGING | $245,350 | ACH | $0 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | TO ACCRUE FOR APPROVED GRANT TO BE FUNDED IN MAY, 2022 | $172,052 | ACH | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 10 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | THE RESEARCH LEADERSHIP GROUP REVIEWS EACH PROPOSAL FOR FIT WITH THE CURE ALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S DISEASE. ALL FUNDED RESEARCHERS MAY BE ASKED TO REVIEW OCCASIONAL PROPOSALS ON A THREE-WEEK TIMELINE AS A CONDITION OF RECEIVING FUNDING. THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT PROPOSAL FITS WITHIN THE ORGANIZATION'S MISSION TO FUND RESEARCH CONTRIBUTING TO A CURE FOR ALZHEIMER'S DISEASE. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY REVIEWER MAY RESULT IN A REQUEST FOR ITERATION OR REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTIONS, OR REJECTION BUT WILL NOT RECEIVE ANY "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION IF A PROPOSAL IS FUNDED. |
| PART III ACCOUNTING METHOD: |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | FISHER ISLAND GOLF | Event1Nm |
| Gross Receipts Event1 | $325,122 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $253,982 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $71,140 | GrossRevenueEvent1Amt |
| Rent Facility Costs Event1 | $47,471 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $4,749 | FoodAndBeverageEvent1Amt |
| Other Direct Expenses Event1 | $26,081 | OtherDirectExpensesEvent1Amt |
| Gross Receipts Total | $325,122 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $253,982 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $71,140 | GrossRevenueTotalEventsAmt |
| Rent Fclty Costs Total Events | $47,471 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $4,749 | FoodAndBeverageTotalEventsAmt |
| Oth Direct Expnss Total Events | $26,081 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $78,301 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$7,161 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (76 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt | IRC SectionIRCSectionDesc |
|---|---|---|---|---|---|---|---|---|
| AMYLYX | ||||||||
| 43 THORNDIKE ST | CAMBRIDGE | MA | 02141 | 464600503 | $78,234 | $0 | PEGASUS CLINICAL STUDY OF AMX0035 IN ALZHEIMER'S DISEASE | |
| BETH ISRAEL DEACONESS MEDICAL CENTER | ||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | 042103881 | $249,026 | $0 | CIRCUITS: A UNIFIED APPROACH TO ACTIONABLE ALZHEIMER'S DISEASE SIGNATURES | 501 (C)(3) |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | $172,500 | $0 | THE ROLE OF MGND-NEURODEGENERATIVE CLEC7A+ MICROGLIA IN AN AD MOUSE MODEL | 501 (C)(3) |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | $172,500 | $0 | TARGETING THE MICROBIOME AND INNATE IMMUNITY | 501 (C)(3) |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | $250,000 | $0 | APOE CONSORTIUM: THE ROLE OF APOE IN MICROGLIA REGULATION IN NEURODEGENERATION | 501 (C)(3) |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | $178,612 | $0 | IMMUNOTHERAPIES TARGETING THE MICROBIOTA TO PREVENT COGNITIVE DECLINE IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | $172,500 | $0 | ROLE OF CHECKPOINT MOLECULE TIM-3 IN REGULATING MICROGLIA IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| BOSTON CHILDRENS HOSPITAL | ||||||||
| 300 LONGWOOD AVE | BOSTON | MA | 02115 | 042774441 | $138,000 | $0 | NEUROINFLAMMATION CONTRIBUTIONS TO ALZHEIMER'S DISEASE: ROLE OF THE CHOROID PLEXUS | 501 (C)(3) |
| HARVARD COLLEGE | ||||||||
| 677 HUNTINGTON AVE | BOSTON | MA | 02115 | 042103580 | $244,496 | $0 | ANALYTICAL AND STATISTICAL TOOLS FOR SEQUENCE ANALYSIS FOR ALZHEIMER'S DISEASE | 501 (C)(3) |
| HOUSTON METHODIST HOSPITAL FOUNDATION | ||||||||
| PO BOX 4384 | HOUSTON | TX | 77210 | 760094743 | $200,000 | $0 | 3DDS CONSORTIUM: UNCOVERING THE MOLECULAR MECHANISMS OF SELECTED DRUG CANDIDATES DERIVED FROM SYSTEMATIC ALZHEIMER'S DRUG REPOSITIONING | 501 (C)(3) |
| HOUSTON METHODIST HOSPITAL FOUNDATION | ||||||||
| PO BOX 4384 | HOUSTON | TX | 77210 | 760094743 | $25,000 | $0 | SUPPLEMENT | 501 (C)(3) |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| BOX 1049 GUSTAVE L LEVY PLACE | NEW YORK | NY | 10026 | 136171197 | $172,500 | $0 | ESTABLISHING THE MOLECULAR AND CELLULAR MECHANISMS AND BIOMARKERS OF APOE4-MEDIATED SUSCEPTIBILITY TO TAU-RELATED COGNITIVE IMPAIRMENTS | 501 (C)(3) |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| BOX 1049 GUSTAVE L LEVY PLACE | NEW YORK | NY | 10026 | 136171197 | $172,500 | $0 | INVESTIGATING BONE MARROW HEMATOPOIESIS AS THE LINK BETWEEN SLEEP FRAGMENTATION AND VASCULAR INFLAMMATION IN AD | 501 (C)(3) |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| BOX 1049 GUSTAVE L LEVY PLACE | NEW YORK | NY | 10026 | 136171197 | $172,500 | $0 | SYSTEMS INTEGRATION AND THERAPEUTICS TRANSLATION. | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $170,907 | $0 | EFFECTS OF CEREBROVASCULAR INSUFFICIENCY AND EXERCISE ON THE AD BRAIN VASCULOMA | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | $0 | DEVELOPMENT OF A MULTICELLULAR BRAIN MODEL TO STUDY BRAIN-VASCULAR-PERIPHERAL IMMUNE CELLS CROSSTALK IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | $0 | NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | $0 | NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | $0 | EFFECTS OF DE-PALMITOYLATION AND ACAT INHIBITION ON AXONAL AB GENERATION VIA MAM-ASSOCIATED PALAPP | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | $0 | ALZHEIMER'S DISEASE DRUG DISCOVERY AND DEVELOPMENT CONSORTIUM: MODULATING CD33 FUNCTION AND NEUROINFLAMMATION AS A THERAPEUTIC APPROACH FOR ALZHEIMER'S DISEASE | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | $0 | ALZHEIMER'S DISEASE DRUG DISCOVERY AND DEVELOPMENT CONSORTIUM: HIGH-THROUGHPUT DRUG SCREENING FOR ALZHEIMER'S DISEASE USING 3D HUMANNEURAL CULTURE SYSTEMS YR 1 OF 2 | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $115,000 | $0 | (YR 2) BRAIN ENTRY & EXIT CONSORTIUM: HUMAN 3D NEUROVASCULAR INTERACTION AND MENINGEAL LYMPHATICS MODELS WITH APPLICATION TO ALZHEIMER'S DISEASE | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | $0 | G2T, AD4, ACTFAST AND GENERAL SCIENTIFIC SUPPORT | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $250,000 | $0 | CHARACTERIZING GUT MICROBIOME SYNERGY WITH EMPHASIS ON MYCOBIOME AND ITS IMPACT ON ALZHEIMER'S DISEASE (AD) PATHOLOGY IN AD MOUSE MODELS | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $58,090 | $0 | HIGH-THROUGHPUT DRUG SCREENING FOR ALZHEIMER'S DISEASE USING 3D HUMAN | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $25,000 | $0 | MODULATING CD33 FUNCTION AND NEUROINFLAMMATION AS A THERAPEUTIC APPROACH FOR AD | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $300,000 | $0 | UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER'S PATHOLOGY | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | $0 | TAU AND B-AMYLOID ARE INNATE IMMUNE ANTIMICROBIAL | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $1,495,000 | $0 | THE CURE ALZ ALZHEIMER'S GENOME PROJECT | 501 (C)(3) |
| MAYO CLINIC | ||||||||
| 200 FIRST ST SW | ROCHESTER | MN | 55905 | 416011702 | $172,500 | $0 | THE ROLE OF CLUSTERIN IN TAU PATHOLOGY | 501 (C)(3) |
| MAYO CLINIC | ||||||||
| 200 FIRST ST SW | ROCHESTER | MN | 55905 | 416011702 | $172,500 | $0 | PATIENT-BASED STRUCTURAL AND FUNCTIONAL BIOLOGY OF TAUOPATHIES (YEAR 2) | 501 (C)(3) |
| MAYO CLINIC | ||||||||
| 200 FIRST ST SW | ROCHESTER | MN | 55905 | 416011702 | $172,500 | $0 | HARNESSING MENINGEAL LYMPHATICS AND IMMUNITY TO ALLEVIATE APOE4-INDUCED BRAIN DYSFUNCTION | 501 (C)(3) |
| MAYO CLINIC | ||||||||
| 200 FIRST ST SW | ROCHESTER | MN | 55905 | 416011702 | $250,000 | $0 | APOE CONSORTIUM: COUNTERACTING PATHOGENIC EVENTS IN AD WITH PERIPHERAL OR CENTRAL APOE | 501 (C)(3) |
| MAYO CLINIC JACKSONVILLE | ||||||||
| 4500 SAN PABLO ROAD S | JACKSONVILLE | FL | 32224 | 593337028 | $172,500 | $0 | ABCA7 LOSS OF FUNCTION IN AGING AND ALZHEIMER'S DISEASE | 501 (C)(3) |
| MAYO CLINIC JACKSONVILLE | ||||||||
| 4500 SAN PABLO ROAD S | JACKSONVILLE | FL | 32224 | 593337028 | $172,500 | $0 | TARGETING MICROGLIAL TSG 101 FOR SYNAPTIC PROTECTION AND COGNITIVE ENHANCEMENT IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | ||||||||
| 550 1ST AVE R607 | NEW YORK | NY | 10016 | 135562308 | $174,754 | $0 | THE ROLE OF ASTROCYTE-DERIVED TOXIC LIPIDS MEDIATING DEGENERATION IN AD | 501 (C)(3) |
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | ||||||||
| 550 1ST AVE R607 | NEW YORK | NY | 10016 | 135562308 | $250,000 | $0 | NEUROINFLAMMATION CONSORTIUM: INVESTIGATION OF AD RISK ALLELES IN ASTROCYTES FOCUS ON CHOLESTEROL TRANSPORT AND MICROGLIA INTERACTION | 501 (C)(3) |
| THE BROAD INSTITUTE INC | ||||||||
| 415 MAIN ST | CAMBRIDGE | MA | 02142 | 263428781 | $172,500 | $0 | REVEALING NEW GENES AND PATHWAYS AT THE INTERSECTION OF LIPOTOXIC AND GENETIC RISK FOR ALZHEIMER'S DISEASE | 501 (C)(3) |
| THE BROAD INSTITUTE INC | ||||||||
| 415 MAIN ST | CAMBRIDGE | MA | 02142 | 263428781 | $550,000 | $0 | CIRCUITS: CONSORTIUM TO INFER REGULATORY CIRCUITS AND UNCOVER INNOVATIVE THERAPEUTIC STRATEGIES PRODUCTION GROUP | 501 (C)(3) |
| THE ROCKEFELLER UNIVERSITY | ||||||||
| 1230 YORK AVENUE | NEW YORK | NY | 10065 | 131624158 | $172,500 | $0 | APOE CONSORTIUM: REGULATION BY APOE OF SELECTIVE NEURONAL VULNERABILITY TO ALZHEIMER'S DISEASE (YEAR 3) | 501 (C)(3) |
| THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | ||||||||
| 10010 N TORREY PINES ROAD | LA JOLLA | CA | 92037 | 952160097 | $172,500 | $0 | THE ROLE OF ASTROCYTE-SECRETED IGFBP2 IN THE PROGRESSION OF ALZHEIMER'S DISEASE | 501 (C)(3) |
| THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | ||||||||
| 10010 N TORREY PINES ROAD | LA JOLLA | CA | 92037 | 952160097 | $115,000 | $0 | CIRCUITS: IMPACT OF EPIGENETIC AND CELLULAR VARIANTS ON ALZHEIMER'S DISEASE PATHOLOGY | 501 (C)(3) |
| THE TRUSTEES OF BOSTON UNIVERSITY | ||||||||
| 25 BUICK STREET | BOSTON | MA | 02115 | 042103547 | $250,000 | $0 | APOE CONSORTIUM: REGULATION BY APOE OF SELECTIVE NEURONAL VULNERABILITY TO ALZHEIMER'S DISEASE | 501 (C)(3) |
| THE TRUSTEES OF BOSTON UNIVERSITY | ||||||||
| 25 BUICK STREET | BOSTON | MA | 02115 | 042103547 | $172,500 | $0 | ALZHEIMER'S DISEASE DRUG DISCOVERY AND DEVELOPMENT CONSORTIUM: BLOCKING SYNAPTOTOXICITY IN ALZHEIMER'S 3D MODELS | 501 (C)(3) |
| THE TRUSTEES OF BOSTON UNIVERSITY | ||||||||
| 25 BUICK STREET | BOSTON | MA | 02115 | 042103547 | $25,000 | $0 | BLOCKING SYNAPTOTOXICITY IN ALZHEIMER'S 3D MODELS | 501 (C)(3) |
| THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||
| 9500 GILMAN RIVE | LA JOLLA | CA | 92093 | 952872494 | $172,500 | $0 | BRAIN ENTRY & EXIT CONSORTIUM: IDENTIFYING THE BLOOD-BRAIN BARRIER CHANGES DURING ALZHEIMER'S DISEASE | 501 (C)(3) |
| THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||
| 9500 GILMAN RIVE | LA JOLLA | CA | 92093 | 952872494 | $172,500 | $0 | FUNCTIONAL BASIS FOR NOVEL PKC, K56R MUTATION IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||
| 9500 GILMAN RIVE | LA JOLLA | CA | 92093 | 952872494 | $291,374 | $0 | CONTINUING STUDIES OF THE EFFECTS OF GSM 776890 ADMINISTRATION ON AMYLOID SPECIES AND MICROGLIOSIS IN OLDER ALZHEIMER'S MODEL MICE | 501 (C)(3) |
| THE UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||
| 9500 GILMAN RIVE | LA JOLLA | CA | 92093 | 952872494 | $172,500 | $0 | THE NEDD4-1 AND PKCA CONNECTION IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||
| UNIVERSITY PARK | LOS ANGELES | CA | 90089 | 951642394 | $191,008 | $0 | PROTECTION AGAINST APOE4 WITH LONGEVITY-PROMOTING INTERVENTIONS | 501 (C)(3) |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||
| UNIVERSITY PARK | LOS ANGELES | CA | 90089 | 951642394 | $257,679 | $0 | AIR POLLUTION AND AD RISK INTERACT WITH PREMATURE AGING OF NEURAL STEM CELLS AND APOE ALLELES | 501 (C)(3) |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||
| UNIVERSITY PARK | LOS ANGELES | CA | 90089 | 951642394 | $172,500 | $0 | AIR POLLUTION AND AD RISK INTERACT WITH PREMATURE AGING OF NEURAL STEM CELLS AND APOE ALLELES | 501 (C)(3) |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||
| UNIVERSITY PARK | LOS ANGELES | CA | 90089 | 951642394 | $250,000 | $0 | CELLULAR AND MOLECULAR STUDIES OF APOE REGULATION OF BLOOD-BRAIN BARRIER, SYNAPTIC AND NEURONAL FUNCTIONS AND PROTECTION STRATEGIES IN MOUSE MODELS WITH AND WITHOUT ALZHEIMER'S PATHOLOGY | 501 (C)(3) |
| UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | ||||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | 752556007 | $250,000 | $0 | MECHANISMS OF TAU PROPAGATION ACROSS THE PLASMA MEMBRANE | 501 (C)(3) |
| UNIVERSITY OF VIRGINIA | ||||||||
| 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903 | 546001796 | $172,500 | $0 | TARGETING A MASTER INNATE IMMUNE ADAPTOR MOLECULE IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| UNIVERSITY OF VIRGINIA | ||||||||
| 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903 | 546001796 | $229,249 | $0 | ADULT HUMAN INEURONS: A NEXT GENERATION DRUG SCREENING PLATFORM FOR ALZHEIMER'S DISEASE | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | ||||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $250,000 | $0 | BRAIN ENTRY & EXIT CONSORTIUM: CROSSTALK OF CNS BARRIERS AND CLEARANCE ROUTES IN HOMEOSTASIS AND ALZHEIMER'S DISEASE | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | ||||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $172,500 | $0 | NEURONAL SUBTYPE-SPECIFIC MODELING OF ALZHEIMER'S DISEASE BY DIRECT NEURONAL REPROGRAMMING OF PATIENT FIBROBLASTS | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | ||||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $300,000 | $0 | APOE CONSORTIUM: UNDERSTANDING THE EFFECT OF APOE ON TAU-MEDIATED NEURODEGENERATION | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | ||||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $172,500 | $0 | CONTRIBUTION OF SKULL BONE MARROW-DERIVED CELLS TO ALZHEIMER'S DISEASE | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | ||||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $172,500 | $0 | UNDERSTANDING THE ROLE OF NATURAL AB-SPECIFIC B CELL RESPONSES IN AD PROGRESSION | 501 (C)(3) |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | ||||||||
| 1167 YORK AVE | NEW YORK | NY | 10065 | 136094042 | $172,500 | $0 | BRAIN ENTRY AND EXIT CONSORTIUM: LYMPHATICS AND CNS FLUID HOMEOSTASIS | 501 (C)(3) |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | ||||||||
| 1167 YORK AVE | NEW YORK | NY | 10065 | 136094042 | $250,000 | $0 | DEVELOPMENT OF HUMAN CGAS INHIBITORS TO TREAT ALZHEIMER'S DISEASE | 501 (C)(3) |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | ||||||||
| 1167 YORK AVE | NEW YORK | NY | 10065 | 136094042 | $172,500 | $0 | ROLE OF MICROGLIA IN DEGRADATION AND TRIMMING OF ALZHEIMER'S AMYLOID BETA | 501 (C)(3) |
| WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH | ||||||||
| 9 CAMBRIDGE CENTER | CAMBRIDGE | MA | 02142 | 061043412 | $307,500 | $0 | CIRCUITS: IMPACT OF GENETIC, EPIGENETIC AND CELLULAR VARIANTS ON ALZHEIMER'S DISEASE PATHOLOGY | 501 (C)(3) |
| YALE UNIVERSITY | ||||||||
| 333 CEDAR ST | NEW HAVEN | CT | 06510 | 060646973 | $114,679 | $0 | 2021 BEE: BENVENISTE TANNENBAUM: BRAIN ENTRY & EXIT CONSORTIUM: GLYMPHATIC-LYMPHATIC COUPLING IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| YALE UNIVERSITY | ||||||||
| 333 CEDAR ST | NEW HAVEN | CT | 06510 | 060646973 | $172,500 | $0 | THE NEUROPROTECTIVE GLIAL BARRIER: A MULTICELLULAR REACTION WITH THERAPEUTIC POTENTIAL IN AD | 501 (C)(3) |
| THE BAYLOR COLLEGE OF MEDICINE | ||||||||
| 1 BAYLOR PLAZA | HOUSTON | TX | 77030 | 741613878 | $167,920 | $0 | ELUCIDATING THE ROLE OF SOLUBLE EPOXIDE HYDROLASE AND ARACHIDONIC ACID METABOLISM IN NEUROINFLAMMATION AND ALZHEIMER'S DISEASE | 501 (C)(3) |
| CARNEGIE MELLON UNIVERSITY | ||||||||
| 500 FORBES AVE | PITTSBURGH | PA | 15213 | 250969449 | $200,000 | $0 | CIRCUITS: INTERPRETING ALZHEIMER'S DISEASEASSOCIATED GENETIC VARIATION AT ENHANCER REGIONS | 501 (C)(3) |
| MASSACHUSETTS INSTITUTE OF TECHONOLOGY | ||||||||
| 77 MASSACHUSETTS AVE | CAMBRIDGE | MA | 02139 | 042103597 | $100,000 | $0 | (YR 2) BRAIN ENTRY & EXIT CONSORTIUM: HUMAN 3D NEUROVASCULAR INTERACTION AND MENINGEAL LYMPHATICS MODELS WITH APPLICATION TO ALZHEIMER'S DISEASE | 501 (C)(3) |
| MEMORIAL SLOAN KETTERING CANCER | ||||||||
| 1250 1ST AVE | NEW YORK | NY | 10065 | 131924236 | $172,500 | $0 | THE ROLE OF IFITM3 AND GAMMA SECRETASE IN MICROGLIA | 501 (C)(3) |
| NORTHWESTERN UNIVERSITY | ||||||||
| 633 CLARK ST | EVANSTON | IL | 60208 | 362167817 | $164,314 | $0 | INTERROGATING LEVETIRACETAM'S IMPACT ON AMYLOID PATHOLOGY AND PRESYNAPTIC PROTEOSTASIS IN KNOCK-IN MOUSE MODELS WITH HUMANIZED ABETA | 501 (C)(3) |
| NORTHWESTERN UNIVERSITY | ||||||||
| 633 CLARK ST | EVANSTON | IL | 60208 | 362167817 | $172,500 | $0 | T CELL EPIGENETICS IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| STONYBROOK UNIVERSITY | ||||||||
| 100 NICILSS RD | STONEY BOOK | NY | 11794 | 161514621 | $50,051 | $0 | 3DDS CONSORTIUM: PROTEOMICS OF ALZHEIMER'S DISEASE 3D CULTURES | 501 (C)(3) |
| THE BRAIN DONOR PROJECT | ||||||||
| PO BOX 111002 | NAPLES | FL | 34108 | 812333601 | $35,050 | $0 | TARGET RECRUITMENT OF UNDERREPRESENTED AMERICANS FOR BRAIN DONOR REGISTRATION | 501 (C)(3) |
| UNVERSITY OF KENTUCKY | ||||||||
| 301 PETERSON SERVICE BLDG | LEXINGTON | KY | 40506 | 616001218 | $172,500 | $0 | APOLIPOPROTEIN E AND IMMUNOMETABOLISM IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 30 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE RESEARCH LEADERSHIP GROUP REVIEWS EACH PROPOSAL FOR FIT WITH THE CURE ALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S DISEASE. ALL FUNDED RESEARCHERS MAY BE ASKED TO REVIEW OCCASIONAL PROPOSALS ON A THREE-WEEK TIMELINE AS A CONDITION OF RECEIVING FUNDING. THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT PROPOSAL FITS WITHIN THE ORGANIZATION'S MISSION TO FUND RESEARCH CONTRIBUTING TO A CURE FOR ALZHEIMER'S DISEASE. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY REVIEWER MAY RESULT IN A REQUEST FOR ITERATION OR REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTIONS, OR REJECTION BUT WILL NOT RECEIVE ANY "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION IF A PROPOSAL IS FUNDED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (6 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TIMOTHY ARMOUR | ||||||||||||||
| PRESIDENT & CEO | $277,005 | $0 | $0 | $0 | $0 | $0 | $9,315 | $0 | $0 | $0 | $286,320 | $0 | $0 | $0 |
| BARBARA CHAMBERS | ||||||||||||||
| EVP MARKETING & COMM. | $204,402 | $0 | $0 | $0 | $0 | $0 | $7,410 | $0 | $10,291 | $0 | $222,103 | $0 | $0 | $0 |
| KATHARINE HERMAN | ||||||||||||||
| EVP DEVELOPMENT | $408,231 | $0 | $0 | $0 | $0 | $0 | $13,395 | $0 | $15,043 | $0 | $436,669 | $0 | $0 | $0 |
| JOHN SLATTERY | ||||||||||||||
| SVP MAJOR GIFTS | $185,684 | $0 | $0 | $0 | $0 | $0 | $6,433 | $0 | $0 | $0 | $192,117 | $0 | $0 | $0 |
| MARGARET SMITH | ||||||||||||||
| EVP, RESEARCH ADMIN | $206,085 | $0 | $0 | $0 | $0 | $0 | $7,528 | $0 | $13,539 | $0 | $227,152 | $0 | $0 | $0 |
| MAHUA DASGUPTA | ||||||||||||||
| SR. PHILANTROPIC ADVISOR | $165,782 | $0 | $0 | $0 | $0 | $0 | $6,121 | $0 | $14,566 | $0 | $186,469 | $0 | $0 | $0 |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp
Name Of Interested NameOfInterested
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PROPER VILLIANS INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship Description | A PRINCIPAL OF THE VENDOR IS THE SPOUSE OF A KEY EMPLOYEE | RelationshipDescriptionTxt |
| Transaction | $121,411 | TransactionAmt |
| Transaction | CREATIVE AND PRODUCTION SERVICES | TransactionDesc |
| Sharing Of Revenues | 0 | SharingOfRevenuesInd |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 97 | ContributionCnt |
| Noncash Contributions Rpt F990 | $5,161,866 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | SALE PRICE | MethodOfDeterminingRevenuesTxt |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | AUCTION ITEMS | Desc |
| Contribution | 0 | ContributionCnt |
| Noncash Contributions Rpt F990 | $46,800 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | DONOR STATED VALUE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | Yes (1) | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 32B: | FormAndLineReferenceDesc |
| Explanation | WHEN STOCK IS RECEIVED AS A CONTRIBUTION IT IS SOLD IMMEDIATELY UPON RECEIPT OR SOON THEREAFTER AS IS PRACTICAL THROUGH FIRST REPUBLIC BANK AND BANK OF NEW YORK/MELLON. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | JEFFREY MORBY AND JACQUELINE MORBY ARE BOTH DIRECTORS AND SPOUSES. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS PREPARED BY THE EXTERNAL AUDITORS AND REVIEWED BY THE PRESIDENT AND CONTRACT CFO. REVISIONS, CORRECTIONS, ETC. ARE MADE AS NECESSARY. ONCE ALL ARE SATISFIED WITH THE FORM, IT IS FINALIZED AND A COPY IS SENT TO ALL BOARD MEMBERS. |
| FORM 990, PART VI, SECTION B, LINE 12C | EACH YEAR THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS PROVIDED TO ALL OFFICERS, DIRECTORS AND KEY EMPLOYEES. THESE PEOPLE ARE ASKED TO REVIEW THE POLICY AND SIGN A STATEMENT INDICATING THAT THEY UNDERSTAND THE POLICY AND HAVE REPORTED ALL POTENTIAL CONFLICTS DURING THE PAST YEAR IN ACCORDANCE WITH THE POLICY AND WILL REPORT ALL POTENTIAL CONFLICTS DURING THE COMING YEAR. ALL POTENTIAL CONFLICTS ARE EVALUATED BY THE BOARD TO DETERMINE IF A CONFLICT ACTUALLY EXISTS. IN THOSE INSTANCES WHERE THE POTENTIAL TRANSACTION IS A CONFLICT, THE BOARD EXAMINES THE TRANSACTION AND A VOTE IS TAKEN (WITH THOSE INVOLVED RECUSING THEMSELVES) AS TO WHETHER THE ORGANIZATION WILL ENTER INTO THE TRANSACTION. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPARABILITY DATA IS SUBMITTED ANNUALLY TO THE EXECUTIVE COMMITTEE FOR COMPENSATION APPROVAL FOR THE PRESIDENT AND ALL OTHER EMPLOYERS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST AND AT THE ORGANIZATION'S WEBSITE. |
Comments